Seiya Ichihara Hirokazu Ogino Hiroto Yoneda Keiko Haji Kozo Kagawa Kojin Murakami Masato Mima Yu Aoi Atsushi Mitsuhashi Yuki Tsukazaki Yohei Yabuki Ryohiko Ozaki Seidai Sato Hiroshi Nokihara Yasuhiko Nishioka
10.1016/j.rmcr.2022.101797
Respir Med Case Rep
2022 Dec 15;41:101797.
alk, anaplastic lymphoma kinase anas, anti-nuclear antibodies ars, aminoacyl trna synthetases ass, anti-synthetase syndrome anti-aminoacyl-trna synthetase antibody ctcae, common terminology criteria for adverse events egfr, epidermal growth factor receptor ggo, ground-glass opacity hp, hypersensitivity pneumonitis hrct, high-resolution computed tomography icis, immune checkpoint inhibitors iim, idiopathic inflammatory myopathy ild, interstitial lung disease immune checkpoint inhibitor nsclc, non-small-cell lung cancer nsip, nonspecific interstitial pneumonia non-small-cell lung cancer op, organizing pneumonia os, overall survival pd-1, programmed cell death-1 pd-l1, programmed cell death-ligand-1 pfs, progression-free survival pneumonitis rr, response rate uip, usual interstitial pneumonia iraes, immune-related adverse events
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/36583061/
Case Reports
PMC9792951
36583061
Immune checkpoint inhibitor-related pneumonitis with atypical radiologic features in a patient with anti-aminoacyl-tRNA synthetase antibody
2022